IONIS PHARMACEUTICALS INC (IONS)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FirstSun Capital Bancorp - FSUN
Communiqué de presse : Rapport financier semestriel 2026 de Sanofi
Press Release: Sanofi’s half-year financial report for 2026
How CNH precision technology is helping family farms turn data into better decisions
Decent Holding Advances AI-Powered Health Data Infrastructure Alongside Community Healthcare Network Expansion
Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel
Clinical trial NCT07090655 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-04-07 3. primary completion date: 2026-04-01 → 2026-04-07 4. enrollment: 38 → 30 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07406334: status: NOT_YET_RECRUITING → RECRUITING.
Clinical trial NCT05735483: enrollment: 310 → 333 participants.